In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest
- PMID: 17194821
- PMCID: PMC1803125
- DOI: 10.1128/AAC.01539-06
In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest
Abstract
We evaluated the activities of amphotericin B, itraconazole, voriconazole, caspofungin, and posaconazole against zygomycetes by CLSI M38-A, Etest and Sensititre. The most active drug was posaconazole, followed by amphotericin B and itraconazole. The correlation of the Etest and Sensititre with CLSI M38-A was moderate for posaconazole but poor for the others.
References
-
- Berenguer, J., P. Munoz, F. Parras, V. Fernandez-Baca, T. Hernandez-Sampelayo, and E. Bouza. 1994. Treatment of deep mycoses with liposomal amphotericin B. Eur. J. Clin. Microbiol. Infect. Dis. 13:504-507. - PubMed
-
- Bouza, E., P. Munoz, and J. Guinea. 2006. Mucormycosis: an emerging disease? Clin. Microbiol. Infect. 12(Suppl. 7):7-23. - PubMed
-
- Brugiere, O., G. Dauriat, H. Mal, R. Marrash-Chalha, M. Fournier, O. Groussard, M. Besnard, G. Leseche, and B. Dupont. 2005. Pulmonary mucormycosis (zygomycosis) in a lung transplant recipient: recovery after posaconazole therapy. Transplantation 80:1361-1362. - PubMed
-
- Reference deleted.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
